Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells (original) (raw)
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on:
1Department of Oncology, Graduate School of Pharmaceutical Science, Nagoya City University, Nagoya 467-8603; 2Division of Virology, Aichi Cancer Centre Research Institute, Nagoya 464-8681; 3Department of Medical Technology, Nagoya University Graduate School of Health Sciences, Nagoya 461-8673; 4Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Nagoya; 5Department of Molecular and Cellular Pathobiology and Therapeutics, Nagoya City University School of Pharmaceutical Sciences, Nagoya 467-8603; 6Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu 502-8585; 7Department of Cell Signaling, Gifu University Graduate School of Medicine, Gifu 501-1194; 8Research Complex for the Medicine Frontiers, Aichi Medical University, Aichi 480-1195; and 9Department of Microbiology and Molecular Cell Biology, Nihon Pharmaceutical University, Saitama 362-0806, Japan
Search for other works by this author on: